Jul. 15 at 4:31 PM
$SNWV Not surprised. We were screwed when this happened:
SANUWAVE officially licensed and sold its intravascular shockwave patent portfolio to a third-party licensee (widely understood in the medical device industry to be related to Shockwave's domain). Key Facts of the Agreement The Original Agreement: On March 6, 2024, SANUWAVE Health granted an exclusive license and an option to purchase its intravascular shockwave patents to a third-party licensee in exchange for
$2.5 million. The Portfolio Sale: In August 2025, the licensee officially exercised the option to acquire the patents entirely, resulting in an additional
$5 million cash payment to SANUWAVE. The Legal Standing: Because the technology was legally transferred through paid, contractually sound licensing and acquisition agreements, no patent theft or unauthorized infringement took place between the entities.
J&J bought out Shockwave. In hindsight I should've bought SWAV instead.